Team illness prevention strategy (TIPS) is associated with a 59% reduction in acute illness during the Super Rugby tournament: a control-intervention study over 7 seasons involving 126 850 player days.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
Feb 2020
Historique:
accepted: 16 07 2019
pubmed: 3 8 2019
medline: 23 2 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

To determine whether a team illness prevention strategy (TIPS) would reduce the incidence of acute illness during the Super Rugby tournament. We studied 1340 male professional rugby union player seasons from six South African teams that participated in the Super Rugby tournament (2010-2016). Medical staff recorded all illnesses daily (126 850 player days) in a 3-year control (C: 2010-2012; 47 553 player days) and a 4-year intervention (I: 2013-2016; 79 297 player days) period. A five-element TIPS was implemented in the I period, following agreement by consensus. Incidence rate (IR: per 1000 player days; 95% CI) of all acute illnesses, illness by main organ system, infectious illness and illness burden (days lost due to illness per 1000 player days) were compared between C and I period. The IR of acute illness was significantly lower in the I (5.5: 4.7 to 6.4) versus the C period (13.2: 9.7 to 18.0) (p<0.001). The IR of respiratory (C=8.6: 6.3 to 11.7; I=3.8: 3.3 to 4.3) (p<0.0001), digestive (C=2.5: 1.8 to 3.6; I=1.1: 0.8 to 1.4) (p<0.001), skin and subcutaneous tissue illness (C=0.7: 0.4 to 1.4; I=0.3: 0.2 to 0.5) (p=0.0238), all infections (C=8.4: 5.9 to 11.9; I=4.3: 3.7 to 4.9) (p<0.001) and illness burden (C=9.2: 6.8 to 12.5; I=5.7: 4.1 to 7.8) (p=0.0314) were significantly lower in the I versus the C period. A TIPS during the Super Rugby tournament was associated with a lower incidence of all acute illnesses (59%), infectious illness (49%) and illness burden (39%). Our findings may have important clinical implications for other travelling team sport settings.

Identifiants

pubmed: 31371338
pii: bjsports-2019-100775
doi: 10.1136/bjsports-2019-100775
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-249

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CR is the chairman of the South Africa Rugby Football Union Medical Committee.

Auteurs

Martin Schwellnus (M)

Sport, Exercise Medicine and Lifestyle Institute (SEMLI) and Section Sports Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa mschwell@iafrica.com.
Research Centre, International Olympic Committee, Pretoria, South Africa.

Charl Janse van Rensburg (C)

Biostatistics Unit, South African Medical Research Council, Tygerberg, South Africa.

Helen Bayne (H)

Sport, Exercise Medicine and Lifestyle Institute (SEMLI) and Department of Physiology, University of Pretoria, Pretoria, South Africa.

Wayne Derman (W)

Research Centre, International Olympic Committee, Pretoria, South Africa.
Institute for Sport and Exercise Medicine (ISEM), Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa.

Clint Readhead (C)

Medical Department, South African Rugby Union, Cape Town, South Africa.

Rob Collins (R)

Medical Department, Golden Lions Rugby Union, Johannesburg, South Africa.

Alan Kourie (A)

Medical Department, Sharks Rugby Union, Durban, South Africa.

Jason Suter (J)

Medical Department, Stormers Rugby Union, Cape Town, South Africa.

Org Strauss (O)

Medical Department, Blue Bulls Rugby Union, Pretoria, South Africa.

Nicola Sewry (N)

Sport, Exercise Medicine and Lifestyle Institute (SEMLI), University of Pretoria, Pretoria, South Africa.

Esme Jordaan (E)

Biostatistics Unit, South African Medical Research Council, Tygerberg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH